Y-Intercept (HK)’s CONMED CNMD Stock Holding History

Y-Intercept (HK)’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$420K	Sell	9,094 -7,970	-47%	-$365K	0.01%	1340
2026 Q2	$559K	Buy	+17,064	New	+$614K	0.01%	1283
2026 Q1	–	Sell	-43,424	Closed	-$1.76M	–	1615
2025 Q4	$1.76M	Buy	43,424 +20,135	+86%	+$876K	0.04%	678
2025 Q3	$1.1M	Buy	+23,289	New	+$1.21M	0.03%	940
2024 Q3	–	Sell	-10,105	Closed	-$700K	–	1375
2024 Q2	$700K	Buy	10,105 +1,265	+14%	+$92.3K	0.04%	668
2024 Q1	$708K	Buy	8,840 +3,737	+73%	+$333K	0.05%	537
2023 Q4	$559K	Buy	+5,103	New	+$528K	0.05%	541
2023 Q2	–	Sell	-4,711	Closed	-$489K	–	1329
2023 Q1	$489K	Buy	+4,711	New	+$456K	0.06%	541
2022 Q2	–	Sell	-3,249	Closed	-$483K	–	903
2022 Q1	$483K	Buy	+3,249	New	+$454K	0.11%	277

Other funds holding CNMD

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Tributary Capital Management Omaha, Nebraska $1.09B AUM 35.37% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $45.4B AUM 34.02% 1-Year Est. Return

Y-Intercept (HK)'s CNMD Position: Q3 2026 in Review

Y-Intercept (HK) reduced its CONMED (CNMD) stake by 47% in Q3 2026, selling an estimated $365K and leaving 9,094 shares worth $420K. The position accounts for 0.01% of the portfolio, ranked #1340.

Y-Intercept (HK) first reported a position in CNMD in Q1 2022 and has held it in 9 quarters since. The position peaked at $1.76M in Q4 2025. 143 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.

Y-Intercept (HK) held 9,094 shares of CONMED worth $420K as of Q3 2026.
Y-Intercept (HK) sold 7,970 CONMED shares in Q3 2026, an estimated $365K.
CONMED made up 0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1340 holding.
Y-Intercept (HK) first reported a position in CONMED in Q1 2022 and has held it in 9 quarters since.
Y-Intercept (HK)'s CONMED position peaked at $1.76M in Q4 2025.
143 funds tracked by Wall St. Rank held CONMED as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.